MPM Oncology Innovations Fund GP LLC, 10% Owner at Werewolf Therapeutics, Inc. (HOWL), sold 226,427 shares at $0.94 ($210K) on 2025-11-19, disclosed to the SEC on 2025-11-20.
Scheduled sale ($210k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.93 | 52,627 | $49K | 23.3% |
| 2 | $0.94 | 66,324 | $62K | 29.7% |
| 3 | $0.94 | 66,324 | $62K | 29.7% |
| 4 | $0.89 | 41,152 | $37K | 17.4% |
| Total | $0.93 avg | 226,427 | $210K | 100% |
| Filing → |